title: 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy.
abstract: In 2009, ASCO and the Oncology Nursing Society (ONS) published standards for the safe use of parenteral chemotherapy in the outpatient setting, including issues of practitioner orders, preparation, and administration of medication. In 2011, these were updated to include inpatient facilities. In December 2011, a multistakeholder workgroup met to address the issues associated with orally administered antineoplastics, under the leadership of ASCO and ONS. The workgroup participants developed recommended standards, which were presented for public comment. Public comments informed final edits, and the final standards were reviewed and approved by the ASCO and ONS Boards of Directors. Significant newly identified recommendations include those associated with drug prescription and the necessity of ascertaining that prescriptions are filled. In addition, the importance of patient and family education regarding administration schedules, exception procedures, disposal of unused oral medication, and aspects of continuity of care across settings were identified. This article presents the newly developed standards.
authors.affiliation: Vanderbilt Ingram Cancer Center, Nashville TN; Duke Oncology Network, Durham, NC; University of Michigan Comprehensive Cancer Center, Ann Arbor MI; American Society of Clinical Oncology, Alexandria, VA; Oncology Nursing Society, Pittsburgh, PA; Oncology Nursing Consultant, New Orleans, LA; and Dana Farber Cancer Institute, Boston, MA.
authors.forename: Michael N
authors.initials: MN
authors.lastname: Neuss
authors.forename: Martha
authors.initials: M
authors.lastname: Polovich
authors.forename: Kristen
authors.initials: K
authors.lastname: McNiff
authors.forename: Peg
authors.initials: P
authors.lastname: Esper
authors.forename: Terry R
authors.initials: TR
authors.lastname: Gilmore
authors.forename: Kristine B
authors.initials: KB
authors.lastname: LeFebvre
authors.forename: Lisa
authors.initials: L
authors.lastname: Schulmeister
authors.forename: Joseph O
authors.initials: JO
authors.lastname: Jacobson
mesh_terms: D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D054316:Biomarkers, Pharmacological / Q000032:analysis; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000451:nursing; D009859:Oncology Nursing / Q000592:standards*; D061214:Patient Safety / Q000592:standards*; D017410:Practice Guidelines as Topic; D012956:Societies, Nursing; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D054316:Biomarkers, Pharmacological
references.citation: J Oncol Pract. 2012 Jan;8(1):2-6
references.pmid: 22548003
references.citation: J Clin Oncol. 2011 Jun 20;29(18):2534-42
references.pmid: 21606426
references.citation: Curr Oncol Rep. 2010 Jul;12(4):247-52
references.pmid: 20437116
references.citation: Oncol Nurs Forum. 2011 May;38(3):343-52
references.pmid: 21531684
references.citation: J Clin Oncol. 1997 Jan;15(1):110-5
references.pmid: 8996131
references.citation: Cancer. 2010 May 15;116(10):2455-64
references.pmid: 20225328
references.citation: BMJ. 1996 Nov 16;313(7067):1219-20
references.pmid: 8939095
references.citation: J Clin Oncol. 2009 Nov 10;27(32):5469-75
references.pmid: 19786650
references.citation: J Natl Compr Canc Netw. 2008 Mar;6 Suppl 3:S1-14
references.pmid: 18377852
references.citation: CA Cancer J Clin. 2009 Jan-Feb;59(1):56-66
references.pmid: 19147869
references.citation: J Natl Cancer Inst. 2009 Nov 18;101(22):1534-6
references.pmid: 19880814
references.citation: J Oncol Pract. 2009 Nov;5(6):270-6
references.pmid: 21479069
references.citation: Int J Cancer. 2009 Feb 1;124(3):722-8
references.pmid: 18989899
references.citation: Clin J Oncol Nurs. 2003 Nov-Dec;7(6 Suppl):5-9
references.pmid: 14705494
references.citation: Clin J Oncol Nurs. 2003 Nov-Dec;7(6 Suppl):21-4
references.pmid: 14705496